---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-079497"
form_type: "8-K"
ticker: "PGEN"
cik: "0001356090"
company_name: "PRECIGEN, INC."
filed_at: "2025-08-18T23:59:59+00:00"
generated_at: "2026-05-17T11:49:40.260458+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "medium"
source: SEC EDGAR
---

# Precigen announces FDA approval of PAPZIMEOS (no further details)

## Summary
- US FDA approval of PAPZIMEOS announced via slide deck at August 18, 2025 investor webcast.
- No additional specifics such as indication or market size provided in this filing.
- The approval represents a significant regulatory milestone for Precigen (PGEN).

## SEC filing metadata
- accession: 0001104659-25-079497
- form_type: 8-K
- ticker: PGEN
- cik: 0001356090
- company_name: PRECIGEN, INC.
- filed_at: 2025-08-18T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356090/000110465925079497/0001104659-25-079497-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356090/000110465925079497/tm2523710d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-079497
- JSON: https://secwatch.observer/filing/0001104659-25-079497.json
- Plain text: https://secwatch.observer/filing/0001104659-25-079497.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.